1/19
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
The stress response
combination of things throughout the body in response to stimuli that is threatening to homeostasis Eg. Being attacked (scared), attacking someone (anger), hunger, cold and overheating
Has effects throughout the body
Stimulates the sympathetic and inhibits the parasympathetic nervous system causing less saliva, increased heart rate, constricting blood vessels → high blood pressure and increases sweating
Post ganglionic neurons affect organs using noradrenaline
Systems stimulated during stress: adrenal hormones
hypothalamus releases corticotropin releasing factor (CRF) which stimulates the anterior pituitary gland to release adrenocorticotrophic (ACTH) to the adrenal cortex which causes cortisol to be released which stimulates glucose/ energy to deal with stress
Or adrenal medulla releases adrenaline into the bloodstream which stimulates pre ganglionic neurons
Activation of the stress response
amygdala (central responds to homeostatic challenges e.g. too cold/ hot or medial which responds to psychogenic challenges e.g. anger/ scared)
Subgenual anterior cingulate cortex (sgACC) has indirect activation
Both activate the sympathetic nervous system and the HPA axis
Regulation of the HPA axis
stress needs to go back down in order to not use too much energy
Cortisol levels increase with stress and then gradually decrease with time due to clearing and stopped production
HPA axis: negative feedback
direct negative feedback of cortisol on the PVN via glucocorticoid receptors (GR)
Anterior hippocampus detects too much cortisol in blood using many MR and GR receptors that are sensitive to cortisol so signals to HPA axis to inhibit production (indirect inhibition)
Dorsal anterior cingulate cortex influences how strong the cortisol response is and how long it lasts though indirect inhibition and used of GR receptors → early and intermediate term feedback
Major (unipolar) depression
Symptoms: depressed mood, sleeping problems, fatigue, change in appetite, feelings of worthlessness and lethargy
Has to be persistent and debilitating and not easily explained by outside factors
Twice as common in women (could be skewed statistics as women are more likely to seek help)
Depression and the HPA axis
dysregulated HPA axis is common in affective disorders
Both pathological increases and decreases in cortisol can lead to depressive symptoms
Chronic stress: positive feedback
amygdala stimulates the HPA axis
Glucocorticoids activate the locus coerules which has noradrenergic projections which activate the amygdala → cortisol
Becomes self stimulating due to overactivation
Chronic stress: reduced negative feedback
repeated stimulation by glucocorticoids reduces sensitivity of receptors in the hippocampus
Chronically high glucocorticoids also damage hippocampal neurons → reduction in negative feedback → less control when stressed
Reduction of stress in treatment from depression
Decreased activation of the subgenual ACC (activates the stress response) after a variety of successful treatments for depression
Shows depression treatment works on the stress response
Major depressive disorder and sleep
fall asleep sooner
Go into REM too soon
More interruptions during sleep
Reduction in SWS
Monoamine effects of chronic stress
depletion of noradrenaline from locus coeruleus
Depletion of serotonin from raphe nuclei
Depletion of dopamine from VTA, n accumbens and prefrontal cortex
Major depressive disorder: pharmacological treatments
Targeting mono-amines
Ketamine
Role of mono-amines in depression
reserpine (mono-amine antagonist) induces depression
Lower levels of 5-HIAA in cerebrospinal fluid
Tryptophan depletion experiments
SSRIs - targeting monoamines
SSRI = selective serotonin reuptake inhibitor
usually taken in pill form
Lipophilic
Different pharmacokinetics for different types:
fluoxetine (prozac): slow uptake, half life = 1-4 days
Fluvoxamine (faverin): bit faster, half life = 8-28h
Citalopram (cipramil): bit faster, half life = ~36h
Only work after several weeks as the first two weeks is adaptation of auto receptors
Adaptation of auto receptors (how SSRIs work)
initially, SSRIs increase 5HT levels in the synapse by blocking reuptake →Auto receptors reducing 5HT release through negative feedback → no change in 5HT levels as lower release and more in synapse for longer cancels out
After roughly 2 weeks, the auto receptors adapt (tolerance) to the higher levels of 5HT → reduced negative feedback → gradual increase in release of 5HT
Since 5HT reuptake is still blocked → 5HT levels in the synapse to be above original levels → more 5HT binding to post synaptic receptors
Adult hippocampal neurogenesis
suppressed in animal models of depression
Anti depressants increase neurogenesis
More increase = more effective
Destroying adult neurogenesis prevents antidepressants effects
Exercise increases adult neurogenesis and improves depression symptoms
Ketamine
dissociative anaesthetic and analgesic
Can be snorted, taken in pills or injected
Initial biological half life 10-15 minutes
Ketamine short term effects
low doses = lightness/ euphoria, disconnection and strange perceptions
Higher doses = mind body disconnectedness and k-holing (unresponsive and hallucinations)
Ketamine physiological action
NMDA-R antagonist (Block receptors) responsible for:
anaesthesia
Dissociation and hallucinations
Amnesia
Analgesia